Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stanford J, Stewart"'
Autor:
Charles L, Vogel, Melody A, Cobleigh, Debu, Tripathy, John C, Gutheil, Lyndsay N, Harris, Louis, Fehrenbacher, Dennis J, Slamon, Maureen, Murphy, William F, Novotny, Michael, Burchmore, Steven, Shak, Stanford J, Stewart, Michael, Press
Publikováno v:
Journal of Clinical Oncology. 41:1638-1645
PURPOSE To evaluate the efficacy and safety of first-line, single-agent trastuzumab in women with HER2-overexpressing metastatic breast cancer. PATIENTS AND METHODS One hundred fourteen women with HER2-overexpressing metastatic breast cancer were ran
Autor:
Roger B. Cohen, Caio Rocha-Lima, Jan Baughman, Deryk Loo, Nancy L. Lewis, Lee S. Rosen, Suzanne F. Jones, Howard A. Burris, Lori Kunkel, Stanford J. Stewart, John L. Marshall
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 16(5)
Purpose: RAV12 is a high affinity, internalizing, chimeric IgG1 monoclonal antibody that binds RAAG12, a novel primate-restricted N-linked carbohydrate epitope present on multiple cell surface proteins. RAAG12 is highly expressed on many adenocarcino
Autor:
Eric C. Vonderheid, Madeleine Duvic, Glen Bowen, Stanford J. Stewart, Patricia Bacha, Arturo Molina, Seth R. Stevens, Brian V. Jegasothy, Youn H. Kim, Lauren C. Pinter-Brown, Arthur E. Frankel, Allan Oseroff, David P. Fivenson, Gary S. Wood, Timothy M. Kuzel, Peter W. Heald, Elise A. Olsen, Ann Martin, Fiona E. Craig, Kevin D. Cooper, Michael Glode, Jean Nichols, Michael S. Gordon, Elizabeth Knobler, James M. Reuben, Francine M. Foss
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(2)
PURPOSE: The objective of this phase III study was to determine the efficacy, safety, and pharmacokinetics of denileukin diftitox (DAB389IL-2, Ontak [Ligand Phar-maceuticals Inc, San Diego, CA]) in patients with stage Ib to IVa cutaneous T-cell lymph